ArticleJMIR AI2026
Safety-Filter Fallback on Consumer Health Questions During the Initial Claude Fable 5 Deployment: Observational Study.
Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Independent audits of medical large language models have concentrated on models that answer unsafely rather than those that decline safe questions. In June 2026, Anthropic released Claude Fable 5 with a safeguard that detects requests related to cybersecurity, biology, or chemistry and reroutes them to a fallback model, Claude Opus 4.8. The developer states that this safeguard is deliberately conservative and affects fewer than 5% of sessions. Whether that figure holds for consumer health questions, many containing dense biomedical vocabulary, was unknown. Objective: This study measured how often Claude Fable 5 routed consumer health questions to its fallback model and whether routing varied by clinical domain and framing. Methods: In this observational, point-in-time audit, the first 500 unique prompts in alphabetical order from the HealthSearchQA benchmark (3173 prompts) were each entered once into Claude Fable 5 through the web interface, in a new session with no system prompt and default settings, from June 9 to 12, 2026. Two reviewers independently coded each response as routed to fallback upfront or not routed upfront, with a third adjudicating disagreements. Midgeneration truncation due to a safety interruption was recorded separately. Prompts were labeled by clinical domain, question type, and sensitivity. Rates were reported with Wilson 95% CIs and compared using chi-square tests. Gemini 2.5 Flash served as an independent comparator. Results: Reviewers agreed on 474 of 500 responses (94.8%; Cohen κ=0.90; 95% CI 0.86-0.94). Fable 5 routed 243 (48.6%; 95% CI 44.2%-53.0%) prompts to the fallback. Of the 257 not routed upfront, 236 (91.8%; 95% CI 87.8%-94.6%) were fully answered and 21 (8.2%; 95% CI 5.4%-12.2%) were truncated midgeneration. Fallback routing varied by clinical domain ( Conclusions: Claude Fable 5 routed nearly half of these benchmark consumer health prompts away from the primary model, and routing was associated with clinical domain, question category, and disease vocabulary. Because benignness was not independently adjudicated, wording covaried with clinical content, and the fallback model's subsequent answer was not recorded, these findings describe routing and truncation rather than user-facing refusal or a causal classifier feature. Fallback routing is a measurable safety property that audits should report alongside answer quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.